| 4.2.3 Antimanic drugs |
Link to Suggested Monitoring Requirements of High Risk Drugs
For prophylaxis and treatment of mania. Monitor levels with lithium. A shared care guideline is available for the use of
|
lithium, click here to access it.
|
| |
Carbamazepine
|
Carbamazepine is licensed for partial and secondary generalised tonic-clonic seizures, primary generalised tonic-clonic
|
seizures; trigeminal neuralgia; prophylaxis of bipolar disorder unresponsive to lithium.
|
| |
AMBER Carbamazepine
|
| tablets 100mg, 200mg, 400mg |
| tablets m/r 200mg, 400mg |
| liquid 100mg/5ml |
| |
AMBER SHARED CARE
|
| Lithium carbonate sustained release tablets 200mg, 400mg |
| (Priadel®) - Always prescribe by brand name |
AMBER Valproic acid e/c tablets 250mg, 500mg (Depakote®)
|
| |
| Lamotrigine |
| Lamotrigine is licensed for use as a mood stabiliser in bipolar disease. |
| AMBER Lamotrigine tablets 25mg, 50mg |
| |
| |
| |
| Back to Main Chapter |
| |
| |
| |
| |
| |
| |
| |
| |
| |
All material in this section is aimed at health care professionals, but is information currently held in the public domain, members of the |
| public seeking advice on medicine-related matters are advised to speak with their GP, pharmacist, nurse or contact NHS111 Service |
| Email: info.elmmb@nhs.net |
| Copyright© 2016 East Lancashire Medicines Management Board. |
All rights reserved. Disclaimer/Terms and conditions
|
|
| |
